Literature DB >> 23180357

Windmills and pill mills: can PDMPs tilt the prescription drug epidemic?

Hallam Gugelmann1, Jeanmarie Perrone, Lewis Nelson.   

Abstract

Prescription drug monitoring programs (PDMPs) are state-based registries of prescriptions for specific controlled substances. This overview will describe the history and funding of these databases, address those characteristics thought to be of greatest utility for PDMPs and review current literature regarding PDMP effectiveness and their potential limitations. Although more extensive research on PDMP outcomes is needed, these databases are an essential component in ongoing efforts to establish safe and compassionate prescription opioid stewardship.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23180357      PMCID： PMC3550255          DOI： 10.1007/s13181-012-0273-8

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


  13 in total

1.  Regulation of benzodiazepine prescription.

Authors:  S M Wolfe; P Lurie
Journal:  JAMA       Date:  1992 Jul 22-29       Impact factor: 56.272

2.  Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.

Authors:  Scott M Fishman; Jennifer S Papazian; Susana Gonzalez; Paul S Riches; Aaron Gilson
Journal:  Pain Med       Date:  2004-09       Impact factor: 3.750

3.  Can prescription drug monitoring programs help limit opioid abuse?

Authors:  Hallam M Gugelmann; Jeanmarie Perrone
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

4.  Awareness and utilization of a prescription monitoring program among physicians.

Authors:  Lance Feldman; Kristi Skeel Williams; John Coates; Michele Knox
Journal:  J Pain Palliat Care Pharmacother       Date:  2011-09-21

5.  The influence of prescription monitoring programs on chronic pain management.

Authors:  Jing Wang; Paul J Christo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

6.  Clinical policy: critical issues in the prescribing of opioids for adult patients in the emergency department.

Authors:  Stephen V Cantrill; Michael D Brown; Russell J Carlisle; Kathleen A Delaney; Daniel P Hays; Lewis S Nelson; Robert E O'Connor; Annmarie Papa; Karl A Sporer; Knox H Todd; Rhonda R Whitson
Journal:  Ann Emerg Med       Date:  2012-10       Impact factor: 5.721

7.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz; Theodore J Cicero
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

8.  Prescription drug monitoring programs and death rates from drug overdose.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Hema A Desai
Journal:  Pain Med       Date:  2011-02-18       Impact factor: 3.750

9.  Analytic models to identify patients at risk for prescription opioid abuse.

Authors:  Alan G White; Howard G Birnbaum; Matt Schiller; Jackson Tang; Nathaniel P Katz
Journal:  Am J Manag Care       Date:  2009-12       Impact factor: 2.229

10.  Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine.

Authors:  Vincent Pradel; Elisabeth Frauger; Xavier Thirion; Eléonore Ronfle; Véronique Lapierre; Alain Masut; Christine Coudert; Olivier Blin; Joëlle Micallef
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-01       Impact factor: 2.890
View more
  16 in total

1.  Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.

Authors:  Courtney R Yarbrough
Journal:  Health Serv Res       Date:  2017-01-18       Impact factor: 3.402

2.  Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.

Authors:  Kathryn Hawk; Gail D'Onofrio; David A Fiellin; Marek C Chawarski; Patrick G O'Connor; Patricia H Owens; Michael V Pantalon; Steven L Bernstein
Journal:  Acad Emerg Med       Date:  2017-12-26       Impact factor: 3.451

3.  Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011.

Authors:  Corey S Davis; Matthew Pierce; Nabarun Dasgupta
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

4.  Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses.

Authors:  Magdalena Cerdá; William R Ponicki; Nathan Smith; Ariadne Rivera-Aguirre; Corey S Davis; Brandon D L Marshall; David S Fink; Stephen G Henry; Alvaro Castillo-Carniglia; Garen J Wintemute; Andrew Gaidus; Paul J Gruenewald; Silvia S Martins
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

5.  Opioid Prescribing in a Cross Section of US Emergency Departments.

Authors:  Jason A Hoppe; Lewis S Nelson; Jeanmarie Perrone; Scott G Weiner
Journal:  Ann Emerg Med       Date:  2015-05-04       Impact factor: 5.721

6.  Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application.

Authors:  Hsien-Chang Lin; Zhi Wang; Yi-Han Hu; Kosali Simon; Anne Buu
Journal:  Prev Med       Date:  2022-06-21       Impact factor: 4.637

7.  Deception and Drug Acquisition: Correlates of "Success" Among Drug-Seeking Patients.

Authors:  Amber N Sanders; John M Eassey; John M Stogner; Bryan Lee Miller
Journal:  J Prim Care Community Health       Date:  2016-02-04

8.  A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016.

Authors:  Nathan Smith; Silvia S Martins; June Kim; Ariadne Rivera-Aguirre; David S Fink; Alvaro Castillo-Carniglia; Stephen G Henry; Stephen J Mooney; Brandon D L Marshall; Corey Davis; Magdalena Cerdá
Journal:  Addiction       Date:  2018-10-22       Impact factor: 6.526

9.  Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.

Authors:  Silvia S Martins; William Ponicki; Nathan Smith; Ariadne Rivera-Aguirre; Corey S Davis; David S Fink; Alvaro Castillo-Carniglia; Stephen G Henry; Brandon D L Marshall; Paul Gruenewald; Magdalena Cerdá
Journal:  Int J Drug Policy       Date:  2019-10-15

Review 10.  Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.

Authors:  Kathryn F Hawk; Federico E Vaca; Gail D'Onofrio
Journal:  Yale J Biol Med       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.